DTL was shown to be associated with AKT/mTOR activation, while inhibition of the mTOR pathway inhibited the proliferation of enzalutamide-resistant PCa cells, leading to AR or AR-V degradation [59,60]. This evidence concerns the gene AR and posterior cortical atrophy.